Evaluation of a new immunoassay for cystatin C, based on a double monoclonal principle, in men with normal and impaired renal function

Nephrology Dialysis Transplantation

Volumn 27, Issue 2, 2012, Pages 682-687

  Ristiniemi, Noora ^a   Savage, Caroline ^b   Bruun, Laila ^c   Pettersson, Kim ^a   Lilja, Hans ^b,c   Christensson, Anders ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c LUND UNIVERSITY   (Sweden)

Author keywords

creatinine; cystatin C; glomerular filtration rate; iohexol clearance; renal function

Indexed keywords

CREATININE; CYSTATIN C; IOHEXOL; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; GLOMERULUS FILTRATION RATE; GOLD STANDARD; HUMAN; IMMUNOASSAY; KIDNEY CLEARANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PARTICLE ENHANCED IMMUNOTURBIDIMETRIC ASSAY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; ANTIBODIES, MONOCLONAL; CASE-CONTROL STUDIES; CREATININE; CYSTATIN C; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOASSAY; IOHEXOL; MALE; MIDDLE AGED; REFERENCE VALUES; RENAL INSUFFICIENCY, CHRONIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84856876292     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr350     Document Type: Article

References (22)

1. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9: S16-S23
2. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
3. Shlipak MG, Katz R, Kestenbaum B et al. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly. Atherosclerosis 2009; 204: 298-303
4. Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12
5. Levey AS, Atkins R, Coresh J et al. Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007; 72: 247-259
6. Newman DJ, Thakkar H, Edwards RG et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47: 312-318
7. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 221-226
8. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 2001; 37: 79-83
9. Hojs R, Bevc S, Ekart R et al. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transplant 2006; 21: 1855-1862
10. Maillard N, Mariat C, Bonneau C et al. Cystatin C-based equations in renal transplantation: moving toward a better glomerular filtration rate prediction? Transplantation 2008; 85: 1855-1858
11. Stevens LA, Schmid CH, Greene T et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009; 75: 652-660
12. Van Den Noortgate NJ, Janssens WH, Delanghe JR et al. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old. J Am Geriatr Soc 2002; 50: 1278-1282
13. Burkhardt H, Bojarsky G, Gretz N et al. Creatinine clearance, Cockcroft-Gault formula and cystatin C: estimators of true glomerular filtration rate in the elderly? Gerontology 2002; 48: 140-146
14. Ristiniemi N, Qin QP, Postnikov A et al. Dry-reagent double-monoclonal assay for cystatin C. Clin Chem 2010; 56: 1424-1431
15. Kyhse-Andersen J, Schmidt C, Nordin G et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994; 40: 1921-1926
16. Norlund L, Fex G, Lanke J et al. Reference intervals for the glomerular filtration rate and cell-proliferation markers: serum cystatin C and serum beta 2-microglobulin/cystatin C-ratio. Scand J Clin Lab Invest 1997; 57: 463-470
17. Brochner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30: 271-274
18. Krutzen E, Back SE, Nilsson-Ehle I et al. Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate. J Lab Clin Med 1984; 104: 955-961
19. Grubb A, Nyman U, Bjork J et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem 2005; 51: 1420-1431
20. Rule AD, Larson TS, Bergstralh EJ et al. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004; 141: 929-937
21. Flodin M, Hansson LO, Larsson A. Variations in assay protocol for the Dako cystatin C method may change patient results by 50% without changing the results for controls. Clin Chem Lab Med 2006; 44: 1481-1485
22. Christensson A, Ekberg J, Grubb A et al. Serum cystatin C is a more sensitive and more accurate marker of glomerular filtration rate than enzymatic measurements of creatinine in renal transplantation. Nephron Physiol 2003; 94: 19-27